Drug:
Reaction: PNEUMONIA
20250101 - 20251231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 25099180 |
53 | 1 | |
Mental status changes, Syncope, Sepsis, Heart rate decreased, Tachypnoea, Leukocytosis, Lung opacity, Pneumonia, Cardiomyopathy, Electrocardiogram ST-T segment abnormal, Blood glucose increased, Glomerular filtration rate abnormal, Glycosylated haemoglobin increased, Haemoglobin decreased, C-reactive protein increased, |
||||
CLOZAPINE, OXCARBAZEPINE, |
||||
| 702 | 25099328 |
1 | ||
Pneumonia, |
||||
TACROLIMUS, |
||||
| 703 | 25099830 |
2 | ||
Pneumonia, Peripheral swelling, Joint swelling, Peripheral swelling, |
||||
MACITENTAN, RIOCIGUAT, |
||||
| 704 | 25111869 |
2 | ||
Pneumonia, |
||||
MACITENTAN, TADALAFIL, |
||||
| 705 | 25086698 |
US |
71 | 2 |
Dyspnoea, Influenza, Pneumonia, Atrial fibrillation, Cough, Asthenia, |
||||
UPADACITINIB, |
||||
| 706 | 25086785 |
US |
2 | |
Meniscus injury, Pneumonia, COVID-19, Joint effusion, Influenza, |
||||
ADALIMUMAB, |
||||
| 707 | 25086819 |
US |
2 | |
Pneumonia, Back pain, Weight decreased, Headache, Brain fog, Respiratory symptom, Cough, Sinusitis, Rhinorrhoea, Decreased immune responsiveness, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 708 | 25086825 |
US |
1 | |
Pneumonia, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 709 | 25086857 |
CA |
50 | 2 |
COVID-19, Pneumonia, Avian influenza, |
||||
RISANKIZUMAB-RZAA, |
||||
| 710 | 25086900 |
US |
70 | 1 |
Pneumonia, Acute respiratory failure, End stage renal disease, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ATAZANAVIR, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, |
||||
| 711 | 25086951 |
US |
76 | 1 |
Pneumonia, Platelet count decreased, Malignant neoplasm progression, Troponin T increased, N-terminal prohormone brain natriuretic peptide increased, Red blood cell count decreased, Haemoglobin decreased, Lymphocyte count decreased, Blood creatinine increased, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, CARBOPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASCORBIC ACID, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, CLOPIDOGREL, CLOPIDOGREL BISULFATE, SPIRONOLACTONE, SELENIUM, ROSUVASTATIN CALCIUM, MAGNESIUM OXIDE, FOLIC ACID, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MONTELUKAST, FUROSEMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFEPIME HYDROCHLORIDE, CEFEPIME, CEFTRIAXONE, CEFTRIAXONE SODIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, GUAIFENESIN, METHYLPREDNISOLONE, PREDNISONE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, OXYGEN, 0XYGEN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PSYLLIUM HUSK, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 712 | 25086985 |
US |
69 | 2 |
Pneumonia, |
||||
DUPILUMAB, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, AMLODIPINE BESYLATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, BENZONATATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FUROSEMIDE, OLMESARTAN MEDOXOMIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 713 | 25086987 |
US |
||
Pneumonia, |
||||
TECLISTAMAB, |
||||
| 714 | 25087019 |
CA |
40 | 2 |
Alopecia, Hypercholesterolaemia, Sleep disorder, Gait inability, Depression, Pain in extremity, Headache, Gastrointestinal disorder, Migraine, Fibromyalgia, Hypertension, Helicobacter infection, Osteoarthritis, Pneumonia, Gastrooesophageal reflux disease, Infusion related reaction, Hand deformity, Bursitis, Systemic lupus erythematosus, Blister, Condition aggravated, Rheumatic fever, Psoriatic arthropathy, Obesity, Coeliac disease, Synovitis, Folliculitis, Impaired healing, Lung disorder, Mobility decreased, Glossodynia, Night sweats, Peripheral swelling, Maternal exposure during pregnancy, Stomatitis, Malaise, Pericarditis, Hepatitis, Dry mouth, Confusional state, Lower respiratory tract infection, Facet joint syndrome, Irritable bowel syndrome, Drug hypersensitivity, Blepharospasm, Muscle spasms, Duodenal ulcer perforation, Insomnia, Onychomadesis, Joint range of motion decreased, Drug-induced liver injury, Back injury, Muscular weakness, Fall, Nasopharyngitis, Asthenia, Grip strength decreased, Hypersensitivity, Neck pain, General physical health deterioration, Musculoskeletal stiffness, Lip dry, Injection site reaction, Onychomycosis, Dizziness, Injury, Rash, Muscle injury, Inflammation, Pemphigus, Breast cancer stage III, Memory impairment, Hypoaesthesia, Finger deformity, Epilepsy, |
||||
ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHYLPREDNISOLONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, APREMILAST, |
||||
| 715 | 25087030 |
US |
73 | 2 |
Pneumonia, White blood cell count decreased, Feeling abnormal, Pallor, Motion sickness, Haemoglobin decreased, Fatigue, Headache, Eye disorder, Weight decreased, Influenza, Product packaging difficult to open, Product use issue, Diarrhoea, |
||||
IXAZOMIB, LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, OIL, BIOTIN, HAIR, LISINOPRIL, IBUPROFEN, ERGOCALCIFEROL, |
||||
| 716 | 25087128 |
US |
50 | 2 |
Pneumonia, |
||||
ATOVAQUONE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, LOSARTAN, OXYCODONE, PANTOPRAZOLE, SERTRALINE, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 717 | 25087252 |
PR |
62 | 2 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 718 | 25087301 |
CA |
43 | 2 |
Exposure during pregnancy, Laryngitis, Live birth, Liver function test increased, Liver injury, Lower limb fracture, Lupus-like syndrome, Lupus vulgaris, Maternal exposure during pregnancy, Memory impairment, Mobility decreased, Infusion related reaction, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Injury, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Prescribed underdose, Prescribed overdose, Product use issue, Intentional product use issue, Product use in unapproved indication, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 719 | 25087363 |
JP |
91 | 2 |
Neutropenia, Drug ineffective, Pleural effusion, Pneumonia, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TOLVAPTAN, LANSOPRAZOLE, TRAZODONE HYDROCHLORIDE, METHYLPREDNISOLONE, LINAGLIPTIN, REPAGLINIDE, SODIUM ZIRCONIUM CYCLOSILICATE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, RITUXIMAB, CLONAZEPAM, FUROSEMIDE, |
||||
| 720 | 25087593 |
US |
||
Pneumonia, Myalgia, Acute kidney injury, Muscular weakness, Sepsis, Muscle spasms, Arthralgia, Neuralgia, Hypotension, Hypokinesia, Muscle spasticity, Dyspnoea, |
||||
ASCIMINIB, ASCIMINIB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFAZOLIN SODIUM, CEFAZOLIN, CEFAZOLIN SODIUM, CEFAZOLIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFEPIME HYDROCHLORIDE, CEFEPIME, GUAIFENESIN, GUAIFENESIN, |
||||
| 721 | 25087640 |
BR |
21 | 2 |
Pneumonia, |
||||
VEDOLIZUMAB, |
||||
| 722 | 25087648 |
US |
82 | 2 |
Pneumonia, |
||||
| 723 | 25087671 |
US |
||
Pneumonia, Bronchitis, Sinusitis, Wrong technique in product usage process, Product use in unapproved indication, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 724 | 25087704 |
US |
79 | 1 |
Pneumonia, |
||||
| 725 | 25087746 |
GB |
1 | |
Pneumonia, Abdominal discomfort, Feeling abnormal, Heart rate increased, Chest discomfort, Pain in extremity, Arthralgia, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 726 | 25087777 |
US |
65 | 1 |
Pneumonia, |
||||
GUSELKUMAB, |
||||
| 727 | 25087872 |
US |
||
Pneumonia, Cyst, Bradycardia, |
||||
RAVULIZUMAB, |
||||
| 728 | 25088054 |
JP |
||
Splenic infarction, Pneumonia, Infection, |
||||
MOMELOTINIB, RUXOLITINIB, |
||||
| 729 | 25088115 |
US |
70 | 2 |
Pneumonia, Dyspnoea, Product dose omission issue, Pneumonia, Chronic obstructive pulmonary disease, Dyspnoea, Cough, Insurance issue, |
||||
| 730 | 25088228 |
SG |
72 | 2 |
Pneumonia, |
||||
ADO-TRASTUZUMAB EMTANSINE, |
||||
| 731 | 25088256 |
DE |
82 | 2 |
Meningitis pneumococcal, Pneumonia, Depressed level of consciousness, Speech disorder, Hemiparesis, Pyrexia, General physical health deterioration, Cough, |
||||
ACYCLOVIR, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, CEFTRIAXONE, CEFTRIAXONE SODIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 732 | 25088314 |
US |
||
Pneumonia, |
||||
GANAXOLONE, |
||||
| 733 | 25088368 |
AT |
2 | |
Pneumonia, |
||||
| 734 | 25088639 |
US |
64 | 2 |
Pneumonia, |
||||
SATRALIZUMAB, SATRALIZUMAB, SATRALIZUMAB, |
||||
| 735 | 25088800 |
US |
||
Pneumonia, |
||||
RAVULIZUMAB, |
||||
| 736 | 25088826 |
US |
2 | |
Pneumonia, Alopecia, Abdominal discomfort, Vertigo, Poor quality sleep, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DUPILUMAB, DUPILUMAB, MONTELUKAST SODIUM, MONTELUKAST, RAMIPRIL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, BUPROPION HYDROCHLORIDE, BUDESONIDE, LEVOTHYROXINE, EMPAGLIFLOZIN, |
||||
| 737 | 25088908 |
JP |
84 | 1 |
Pneumonia, Cytokine release syndrome, Cytokine release syndrome, Cytokine release syndrome, Lymphocyte count decreased, |
||||
EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 738 | 25088982 |
CN |
49 | 2 |
Myelosuppression, Pneumonia, Thrombocytopenia, Granulocytosis, Vomiting, Coronavirus infection, Pleural thickening, Full blood count decreased, Light chain analysis decreased, Arteriosclerosis, Pharyngeal disorder, General physical health deterioration, |
||||
CARFILZOMIB, CARFILZOMIB, |
||||
| 739 | 25089114 |
US |
66 | 2 |
Pneumonia, Influenza, Viral infection, Illness, |
||||
DUPILUMAB, |
||||
| 740 | 25089197 |
US |
70 | |
Myocardial infarction, Influenza, Pneumonia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ISOSORBIDE DINITRATE, METOPROLOL TARTRATE, METOPROLOL, GABAPENTIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MAGNESIUM OXIDE, HYDROCHLOROTHIAZIDE, FISH OIL, |
||||
| 741 | 25089219 |
US |
48 | 2 |
Pneumonia, Weight decreased, |
||||
| 742 | 25089254 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
CLONAZEPAM, OMALIZUMAB, RITUXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMINOPHYLLINE, AMLODIPINE BESYLATE, FLUTICASONE PROPIONATE, HYDROMORPHONE HYDROCHLORIDE, PREDNISONE, ROPIVACAINE HYDROCHLORIDE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, |
||||
| 743 | 25089289 |
CA |
52 | 1 |
Chronic obstructive pulmonary disease, Fatigue, Cardiac ventricular thrombosis, Malaise, Pneumonia, Renal vein thrombosis, Splenic thrombosis, Oxygen saturation decreased, Dyspnoea, Abdominal pain, Cardiac failure, Weight decreased, |
||||
SACUBITRIL AND VALSARTAN, ACETYLCYSTEINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, ACETYLCYSTEINE, |
||||
| 744 | 25089292 |
PL |
73 | 2 |
Disease progression, Upper respiratory tract infection, Inflammatory marker increased, Pneumonia, Neutropenia, Chronic obstructive pulmonary disease, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, MOSUNETUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, PREDNISONE, LENALIDOMIDE, DOXORUBICIN, |
||||
| 745 | 25089393 |
CA |
65 | |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
ROSUVASTATIN CALCIUM, ROPIVACAINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, AMLODIPINE BESYLATE, CALCIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, MONTELUKAST SODIUM, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, |
||||
| 746 | 25089420 |
ZA |
78 | |
Illness, Pneumonia, |
||||
RISPERIDONE, |
||||
| 747 | 25089429 |
FR |
2 | |
Death, Acute kidney injury, General physical health deterioration, Language disorder, Pneumonia, Renal tubular necrosis, Bone marrow infiltration, Cytopenia, Pancytopenia, Hypercalcaemia, Ageusia, Gait disturbance, Dehydration, Pain, Weight decreased, Decreased appetite, |
||||
FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 748 | 25089490 |
US |
||
Pneumonia, Seizure, |
||||
GANAXOLONE, |
||||
| 749 | 25089544 |
CA |
65 | |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
ROSUVASTATIN, ROPIVACAINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL, AMLODIPINE BESYLATE, CALCIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, MONTELUKAST SODIUM, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, POLYMYXIN B SULFATE, CEFADROXIL, |
||||
| 750 | 25089747 |
US |
44 | 1 |
Empyema, Pneumonia, Bronchial obstruction, Acute respiratory failure, Atypical pneumonia, Foreign body aspiration, Atelectasis, Drug abuse, Intentional product use issue, |
||||
FENTANYL, |
||||
| 751 | 25089795 |
BR |
79 | 1 |
Intestinal perforation, Pulmonary embolism, Pneumonia, Adenoma benign, |
||||
POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, LOSARTAN POTASSIUM, LOSARTAN, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXLANSOPRAZOLE, |
||||
| 752 | 25089994 |
US |
9 | 1 |
Pneumonia, Asthma, Influenza, Ingrown hair, Injection site mass, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE PROPIONATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 753 | 25089995 |
US |
2 | |
Chronic obstructive pulmonary disease, Asthenia, Chest discomfort, Pneumonia, |
||||
DUPILUMAB, |
||||
| 754 | 25090011 |
CA |
||
Lung neoplasm malignant, Pneumonia, Oedema peripheral, Respiratory syncytial virus infection, COVID-19, Blood bilirubin increased, Blood creatinine increased, Blood urea increased, Gamma-glutamyltransferase increased, Granulocyte count increased, Mean platelet volume increased, Red cell distribution width increased, Mean cell haemoglobin concentration decreased, Monocyte count increased, Basophil count increased, Glomerular filtration rate decreased, |
||||
ECULIZUMAB, ECULIZUMAB, ECULIZUMAB, ECULIZUMAB, TACROLIMUS, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ACYCLOVIR, RANITIDINE, ROSUVASTATIN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ERGOCALCIFEROL, CARVEDILOL, AMLODIPINE BESYLATE, |
||||
| 755 | 25090051 |
US |
56 | 1 |
Pneumonia, |
||||
| 756 | 25090067 |
US |
74 | 2 |
Pneumonia, Hordeolum, |
||||
LENALIDOMIDE, |
||||
| 757 | 25090157 |
US |
2 | |
Device operational issue, Ear discomfort, Pneumonia, Bronchitis, Off label use, |
||||
IPRATROPIUM BROMIDE AND ALBUTEROL, IPRATROPIUM BROMIDE AND ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 758 | 25090176 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
RITUXIMAB, CLONAZEPAM, OMALIZUMAB, |
||||
| 759 | 25090260 |
US |
58 | 2 |
Pneumonia, Respiratory syncytial virus infection, |
||||
DUPILUMAB, INSULIN DEGLUDEC, INSULIN LISPRO, COLLAGEN, MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ZOLPIDEM TARTRATE, FAMOTIDINE, GABAPENTIN, PAROXETINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, METOPROLOL SUCCINATE, MEDROXYPROGESTERONE ACETATE, ATORVASTATIN CALCIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ARIPIPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ORAL SEMAGLUTIDE, INSULIN DETEMIR, OIL, BIOTIN, HAIR, DAPAGLIFLOZIN, |
||||
| 760 | 25090361 |
US |
1 | |
Pneumonia, Therapy non-responder, Cardiac disorder, Pain, |
||||
APREMILAST, PREDNISONE, EPINEPHRINE, ADRENALINUM, CARVEDILOL, |
||||
| 761 | 25090373 |
US |
1 | |
Pneumonia, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 762 | 25090496 |
US |
44 | 2 |
Pneumonia, COVID-19, |
||||
TOFACITINIB, |
||||
| 763 | 25090543 |
GB |
58 | 1 |
Pneumonia, |
||||
LINEZOLID, LINEZOLID, PRETOMANID, |
||||
| 764 | 25090579 |
AU |
56 | 2 |
Anaphylactic reaction, Pneumonia, Respiratory failure, COVID-19, Upper respiratory tract infection, Tongue injury, Viral test positive, Human rhinovirus test positive, Respiratory syncytial virus test positive, Mouth haemorrhage, Drug ineffective, |
||||
PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE, INSULIN ASPART, ANASTROZOLE, ANASTROZOLE TABLETS, APIXABAN, FAMOTIDINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, MONTELUKAST, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, |
||||
| 765 | 25090704 |
US |
65 | 2 |
Pneumonia, |
||||
ABATACEPT, |
||||
| 766 | 25090765 |
CN |
69 | 2 |
Neutropenic sepsis, Respiratory failure, Platelet count decreased, Anaemia, Pneumonia, |
||||
BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, SELINEXOR, SELINEXOR, SELINEXOR, TISLELIZUMAB-JSGR, TISLELIZUMAB-JSGR, TISLELIZUMAB-JSGR, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 767 | 25090810 |
CA |
71 | 2 |
Pneumonia, |
||||
GOLIMUMAB, |
||||
| 768 | 25090827 |
CA |
40 | 2 |
Bursitis, Fall, Finger deformity, Folliculitis, Gastrooesophageal reflux disease, Hepatitis, Hypoaesthesia, Inflammation, Injury, Liver function test increased, Mobility decreased, Muscular weakness, Neck pain, Off label use, Pain in extremity, Pneumonia, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 769 | 25090844 |
US |
71 | 2 |
Pneumonia, |
||||
ABATACEPT, |
||||
| 770 | 25090882 |
2 | ||
Pneumonia, |
||||
MACITENTAN, |
||||
| 771 | 25090883 |
2 | ||
Pneumonia, |
||||
SOTATERCEPT-CSRK, |
||||
| 772 | 25090948 |
2 | ||
Pneumonia, |
||||
SOTATERCEPT-CSRK, |
||||
| 773 | 25091185 |
US |
69 | 1 |
Respiratory syncytial virus infection, Pneumonia, Off label use, |
||||
LENALIDOMIDE, |
||||
| 774 | 25091186 |
CN |
86 | 1 |
Respiratory failure, Pneumonia, Oedema peripheral, |
||||
DENOSUMAB, |
||||
| 775 | 25091190 |
CA |
2 | |
Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, CALCIUM GLUCONATE, DESOGESTREL AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 776 | 25091231 |
US |
57 | 1 |
Chronic obstructive pulmonary disease, Bronchitis, Pneumonia, Intervertebral disc disorder, Acute kidney injury, Hypophagia, Oesophagitis, |
||||
LENALIDOMIDE, CARVEDILOL, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, NITROGLYCERIN, ROSUVASTATIN, VITAMIN E, CREAM, DULOXETINE HYDROCHLORIDE, HYDRALAZINE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 777 | 25091235 |
US |
2 | |
Pneumonia, Cough, Eye irritation, |
||||
DUPILUMAB, |
||||
| 778 | 25091279 |
US |
64 | 1 |
Pneumonia, |
||||
| 779 | 25091939 |
CA |
56 | 1 |
Disease complication, Neoplasm malignant, Hepatic cancer, Obstruction, Pneumonia, |
||||
ADALIMUMAB, |
||||
| 780 | 25091977 |
US |
56 | 2 |
Pneumonia, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 781 | 25092013 |
JP |
||
Pneumonia, |
||||
INCLISIRAN, |
||||
| 782 | 25094079 |
2 | ||
Rash, Pneumonia, Pulmonary oedema, Cardiac disorder, |
||||
IMATINIB MESYLATE, IMATINIB, |
||||
| 783 | 25094362 |
78 | 1 | |
Pneumonia, |
||||
PIRFENIDONE, |
||||
| 784 | 25094526 |
75 | 2 | |
Pneumonia, Myasthenia gravis, |
||||
USTEKINUMAB, |
||||
| 785 | 25081745 |
CA |
43 | 2 |
Pulmonary fibrosis, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Prescribed overdose, Prescribed underdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriasis, Psoriatic arthropathy, Pyrexia, Pneumonia, Oedema peripheral, Intentional product use issue, Off label use, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ERENUMAB-AOOE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 786 | 25081753 |
CA |
49 | 2 |
Syndactyly, Pneumonia, Menopausal symptoms, Atelectasis, Respiratory tract infection, Viral infection, Pyrexia, Blood pressure diastolic increased, Off label use, |
||||
RITUXIMAB-PVVR, |
||||
| 787 | 25081919 |
CA |
52 | 2 |
Pneumonia, Vomiting, Off label use, Pain in extremity, Hypomania, Nausea, Cholelithiasis, Schizophrenia, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 788 | 25081973 |
CA |
69 | 2 |
Pneumonia, |
||||
GUSELKUMAB, |
||||
| 789 | 25081999 |
CH |
82 | 1 |
Death, Influenza, Hypertension, Pulmonary oedema, Hyperventilation, Pneumonia, Renal failure, Urinary tract infection, Prostatitis, Urinary retention, Arteriosclerosis coronary artery, Chronic obstructive pulmonary disease, Pulmonary embolism, Diastolic dysfunction, Lymphoedema, Hernia, Diverticulum intestinal, Blood loss anaemia, Gastrointestinal haemorrhage, Back pain, |
||||
RIVAROXABAN, RIOCIGUAT, TORSEMIDE, PANTOPRAZOLE, MIRTAZAPINE, ZOLPIDEM TARTRATE, ALBUTEROL SULFATE, OXYGEN, 0XYGEN, |
||||
| 790 | 25082011 |
US |
1 | |
Pneumonia, Loss of personal independence in daily activities, Gait inability, Contusion, Renal disorder, Depression, |
||||
SARILUMAB, SARILUMAB, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUPROPION HYDROCHLORIDE, CALCIUM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, LEVOTHYROXINE, PREDNISONE, ERGOCALCIFEROL, |
||||
| 791 | 25082022 |
US |
58 | 1 |
Constipation, Dry eye, Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 792 | 25082082 |
CA |
68 | 2 |
Pneumonia, Gastrooesophageal reflux disease, Skin plaque, Condition aggravated, Aphonia, Nasal congestion, Cough, Dry eye, Headache, Dry mouth, Dyspnoea, Malaise, Osteoporosis, Ear pain, Drug intolerance, Influenza, Oropharyngeal pain, Fatigue, Pruritus, |
||||
OBETICHOLIC ACID, OBETICHOLIC ACID, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TELMISARTAN, |
||||
| 793 | 25082115 |
CA |
59 | 2 |
Blood pressure increased, Body temperature decreased, Breath sounds abnormal, Bronchiectasis, Hypoventilation, Influenza, Malaise, Oxygen saturation decreased, Pancreatic cyst, Pneumonia, Productive cough, Pulmonary congestion, Rales, Respiratory rate increased, Respiratory tract congestion, Retinal oedema, Sputum discoloured, Tachypnoea, Visual impairment, Wheezing, Asthma, Weight decreased, Anaphylactic shock, Dyspnoea, |
||||
ZOLEDRONIC ACID, OMALIZUMAB, OMALIZUMAB, GLYCOPYRROLATE, CICLESONIDE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, THEOPHYLLINE, ALBUTEROL SULFATE, |
||||
| 794 | 25082359 |
US |
61 | 2 |
Pneumonia, Influenza, |
||||
| 795 | 25082377 |
CA |
1 | |
Pneumonia, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 796 | 25082384 |
US |
88 | 1 |
Pneumonia, |
||||
LENALIDOMIDE, |
||||
| 797 | 25082393 |
CA |
80 | 2 |
Pneumonia, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 798 | 25082578 |
US |
38 | 2 |
Pneumonia, |
||||
BIMEKIZUMAB, |
||||
| 799 | 25082677 |
GB |
53 | |
Fournier^s gangrene, Chronic obstructive pulmonary disease, Sepsis, Pneumonia, Myocardial infarction, Fungal test positive, Pleuritic pain, |
||||
DAPAGLIFLOZIN, BISOPROLOL FUMARATE, EPLERENONE, SACUBITRIL AND VALSARTAN, ISOSORBIDE MONONITRATE, RANOLAZINE, EXTENDED-RELEASE, APIXABAN, LANSOPRAZOLE, OXYBUTYNIN, MIRTAZAPINE, IVABRADINE, |
||||
| 800 | 25082693 |
US |
||
Pneumonia, Neutropenia, Thrombocytopenia, Dehydration, Infection, Bronchitis, Infusion related reaction, Diarrhoea, Constipation, Nausea, Upper respiratory tract infection, Oedema peripheral, Fatigue, Asthenia, Pyrexia, Back pain, Muscle spasms, Dyspnoea, Cough, Peripheral sensory neuropathy, Decreased appetite, Anaemia, |
||||
DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28